"This is a moment our entire team has been working toward for years," said Dean Burns, CEO of Ocumetics. "Every milestone we've achieved in recent weeks reflects the dedication, expertise, and sheer determination of our people and partners. We're now just a few days away from transforming the future of vision correction with the first implantation of our groundbreaking accommodating intraocular lens. I couldn't be prouder of what our team has accomplished." Calgary, Alberta – TheNewswire - August 12, 2025 - ...

Calgary, Alberta – TheNewswire - August 5, 2025 - Ocumetics Technology Corp. ("Ocumetics" or the "Company") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce the commencement of patient recruitment for its highly anticipated first-in-human ("FIH") study of the Ocumetics accommodating intraocular lens (the "Ocumetics Lens"). Patient recruitment is expected to be completed in approximately 7days. "We are thrilled to begin recruiting patients for this hi ...

Calgary, Alberta – TheNewswire - July 30, 2025 - Ocumetics Technology Corp. ("Ocumetics" or the "Company") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce that the ethics committee of the clinical site in Mexico City overseeing the first in-human study of the Ocumetics accommodating intraocular lens (the "Ocumetics Lens") has verbally approved the protocol for the study. Formal written approval is expected by August 5, 2025. Dean Burns, CEO of Ocume ...